发明名称 AMINOALCOHOL DERIVATIVES AND THEIR THERAPEUTIC USE
摘要 A compound of formula (1 ) Including pharmaceutically acceptable salts thereof, wherein: R<SUB>1</SUB> is aryl or heteroaryl optionally substituted with R<SUB>8</SUB>; R<SUB>2</SUB> is H or alkyl or CH<SUB>2</SUB> (when forming part of a ring with R<SUB>3</SUB>, R<SUB>4</SUB> or R<SUB>5</SUB>); R<SUB>3</SUB> is H, alkyl, CH<SUB>2</SUB>OH or CH<SUB>2</SUB>OR<SUB>6</SUB> and can be part of a ring with R<SUB>2</SUB>; R<SUB>4</SUB> is H, alkyl, CH<SUB>2</SUB>OH or CH<SUB>2</SUB>OR<SUB>6</SUB> and can be part of a ring with R<SUB>2</SUB>; R<SUB>5</SUB> is H, alkyl, CH<SUB>2</SUB>OH or CH<SUB>2</SUB>OR<SUB>6</SUB> and can be part of a ring with R<SUB>2</SUB>; R<SUB>6</SUB> is H, alkyl, COH, COOR<SUB>9</SUB>, CON(R<SUB>9</SUB>)<SUB>2</SUB>, COR<SUB>9</SUB>, COR<SUB>10</SUB>, COR<SUB>11</SUB>, P(O)<SUB>n</SUB>R<SUB>9</SUB>, P(O)<SUB>n</SUB>R<SUB>10</SUB>S(O)<SUB>n</SUB>R<SUB>10</SUB> or S(O)<SUB>n</SUB>R<SUB>9</SUB>and can be part of a ring with R<SUB>2</SUB>, R<SUB>3</SUB>, R<SUB>4</SUB> or R<SUB>5</SUB>; R<SUB>7</SUB> is H, alkyl, COOR<SUB>9</SUB>, COOR<SUB>11</SUB>, COR<SUB>9</SUB> or CON(R<SUB>9</SUB>)<SUB>2</SUB>, and can be part of a ring with R<SUB>2</SUB>, R<SUB>3</SUB>, R<SUB>4</SUB>, R<SUB>5</SUB> or R<SUB>6</SUB>; R<SUB>8</SUB> is alkyl, CF<SUB>3</SUB>, OR<SUB>9</SUB>, OCOR<SUB>9</SUB>, CONH<SUB>2</SUB>, CN, F, Cl, Br, I, N(R<SUB>9</SUB>)<SUB>2</SUB>, NO<SUB>2</SUB>, NHCHO, NHCONH<SUB>2</SUB>, NHSO<SUB>2</SUB>R<SUB>9</SUB>, CON(R<SUB>9</SUB>)<SUB>2</SUB>, S(O)<SUB>n</SUB>R<SUB>9</SUB>, CH<SUB>2</SUB>OH Or OCON(R<SUB>9</SUB>)<SUB>2</SUB>; R<SUB>9</SUB> is H, alkyl or cycloalkyl; R<SUB>10</SUB> is aryl or heteroaryl (optionally substituted with R<SUB>8</SUB>) or a four to seven membered ring (which is optionally substituted with R<SUB>8</SUB> and can contain one or more additional heteroatoms selected from the list O, S(O)<SUB>n</SUB> and NR<SUB>9</SUB>); R<SUB>11</SUB> is alkyl optionally substituted with R<SUB>8</SUB> or R<SUB>10</SUB>; and n is O, 1 or 2; provided that when R<SUB>3</SUB>, R<SUB>4</SUB> or R<SUB>5</SUB> is CH<SUB>2</SUB>OH then R<SUB>6</SUB> is not H, and that when R<SUB>7</SUB> is H and R<SUB>3</SUB>, R<SUB>4</SUB> and R<SUB>5</SUB> are alkyl then R<SUB>6</SUB> is not H. is of therapeutic use in the treatment of a condition associated with T-cell proliferation or that is mediated by pro- and/or anti-inflammatory cytokines.
申请公布号 WO2008071948(A3) 申请公布日期 2008.07.31
申请号 WO2007GB04752 申请日期 2007.12.12
申请人 SOSEI R & D LTD.;WALMSLEY, ANDREA;LASTERRA, ELENA 发明人 WALMSLEY, ANDREA;LASTERRA, ELENA
分类号 C07C219/22;A61K31/222;A61K31/351;A61P29/00;C07D309/08 主分类号 C07C219/22
代理机构 代理人
主权项
地址